Traditional Chinese medicine for treating liver cancer and preparation method thereof

Abstract

The invention relates to a traditional Chinese medicine for treating liver cancer and a preparation method thereof, and belongs to the field of traditional Chinese medicines, the traditional Chinese medicine for treating liver cancer comprises the following components by weight: 2-8 parts of ginseng, 1-5 parts of patrinia herb, 1-8 parts of bombyx batryticatus, 1-8 parts of angelica, 2-6 parts of rhizoma alismatis, 1-4 parts of ganoderma lucidum, 1-3 parts of monkshood-tuber, 1-5 parts of pseudobulbus cremastrae seu pleiones, 1-4 parts of picrorhiza, 1-4 parts of hedyotis diffusa, 1-8 parts of herba houttuyniae, 1-4 parts of brucea javanica,1-8 parts of safflower carthamus, 1-5 parts of sculellaria barbata, 1-3 parts of astragalus, 3-5 parts of mangnolia officinalis, 1-7 parts of bupleurum, 1-5 parts of danshen, 1-4 parts of medlar, 1-7 parts of ligustrum, 2-4 parts of eclipta, 1-4 parts of schisandra, 1-5 parts of morinda officinalis, 1-6 parts of motherwort, 1-3 parts of polygonum multiflorum ,1-5 parts of polygonum cuspidatum, 1-6 parts of polyporus umbellatus, 2-7 parts of polygonatum, 1-5 parts of red peony, 1-4 parts of root peony peel, 1-8 parts of Chinese yam, 1-3 parts of caulis spatholobi, 1-3 parts of caulis spatholobi, 1-2 parts of hypericum japonicum, 1-8 parts of lithospermum, 1-8 parts of stringy stonecrop, 1-3 parts of placenta hominis and 1-9 parts of licorice, the traditional Chinese medicine has the effects of clearing away heat and toxic materials, promoting blood circulation to remove blood stasis, discharging liver and relieving depression, tonifying spleen and kidney, and inhibiting tumor growth.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine, and relates to a traditional Chinese medicine for treating liver cancer and a preparation method thereof. Background technique [0002] Liver cancer generally refers to primary liver cancer, which is a common malignant tumor of the digestive tract. According to statistics, about 6.35 million cases of malignant tumors are newly discovered every year in the world, of which liver cancer accounts for 260,000 cases (accounting for 4% of malignant tumors), and 42.5% of the 260,000 cases occur in China. [0003] The pathogenesis of liver cancer is the result of multiple factors, multiple steps, and multiple gene mutations. The cause of the disease is closely related to post-hepatitis cirrhosis caused by hepatitis B virus (HBV) infection or hepatitis C virus (HCV) infection, and alcoholic cirrhosis caused by long-term alcoholism. [0004] At present, in addition to surgical resection, Wester...

AI Technical Summary

Problems solved by technology

[0004] At present, in addition to surgical resection, Western medicine mainly uses interventional therapy and chemotherapy in the treatment of liver cancer. However, even with radical resection, there is still a recurrence rate of 60% to 70% within 5 years; , Hepatic function limitation of cirrhosis and other reasons make about 30% of patients with liver cancer who can be surgically resected, while the operability rate of patients with cirrhosis is only 15%-30%

Due to the low selectivity of current chemotherapeutic drugs, while killing tumor cells, they also have a killing effect on normal cells of the body; there is also the risk of inducing secondary tumors and multidrug resistance, these factors severely limit the clinical use of chemotherapeutic drugs

Images